The Swiss Times - Swiss News in English

Novartis China: Biotech Kidney Acquisition

  • By The Swiss Times
  • 5 January 2024

Novartis in China. The Swiss based pharmaceutical group, a company who just made the top 3 Company Rich List for Switzerland, is acquiring the start-up company Sanreno in China.

Novartis China: Biotech Kidney Acquisition

Founded in 2021, the Shanghai-based biotech company specializes in the treatment of kidney diseases and has two active ingredients in the late clinical development phase. This comes quickly after the announcement of a Gene Therapy Deal / rights acquisition from a US based company.

The transaction is one of the few takeovers of a Chinese biotech company by a multinational pharmaceutical company, Sanreno announced on Friday. Sanreno was founded as a joint venture between a consortium of investors and the US company Chinook Therapeutics.

Novartis China Chinook

Novartis acquired Chinook in the summer of 2023 for 3.2 billion dollars. The financial terms of the Sanreno purchase were not disclosed.

According to the statement, Sanreno holds the exclusive rights for the active ingredients Atrasentan and Zigakibart in Greater China and Singapore. Atrasentan showed a significant reduction in proteinuria (excessive excretion of proteins) in a phase 3 study and thus achieved the primary study objective. The antibody Zigakibart to combat the cytokine APRIL received approval in China in October 2023 for the start of phase 3 trials.

Could these acquisitions be a strategy for overcoming the loses they faced in 2023?

©Keystone/SDA

Most Read

Sunday, April 7 – Round Up

7 April 2024
Sunday, April 7 – Round Up
Switzerland may fund French nuclear projects as it grapples with internal issues in the news this Sunday morning.

Swiss Employers Association: Increase Retirement Ages

8 April 2024
Swiss Employers Association: Increase Retirement Ages
Following the rejection of a pension initiative, the Swiss Employers' Association (SAV) recommends a gradual raise in retirement age to 66.

Diehl Defence Will Develop Drones For Swiss Defence Firm Skysec

12 April 2024
Diehl Defence Will Develop Drones For Swiss Defence Firm Skysec
Diehl Defence collaborates with Skysec Defence under a new agreement to enhance drone defense capabilities for military use.

Zurich VC Lakestar Secures $600 Million In New Funds

12 April 2024
Zurich VC Lakestar Secures $600 Million In New Funds
Lakestar successfully closes two new funds, accumulating $600 million, to advance Europe's digital sovereignty.

Stay in Touch!

Noteworthy

Lucerne Asset Manager Jailed For Years
Lucerne Asset Manager Jailed For Years
17 April 2024
Switzerland Moves to Ban Extremist Symbols
Switzerland Moves to Ban Extremist Symbols
17 April 2024